Semiconductors and Electronics

Point-of-Care Market worth 38.12 Billion USD by 2023 | Key Players are Nova Biomedical; AccuBioTech Co., Ltd.; BD; Chembio Diagnostic Systems, Inc.

Point-of-care lipid test market report also provides CAGR value fluctuation in percentage during the forecast period of 2018-2025 for the market. SWOT analysis has been used throughout the report which helps emphasize on the global key manufacturers, market definition, description and analysis of the market competition landscape. With the study of competitor analysis, Medical Devices industry can get know how of the strategies of key players in the market that includes but are not limited to new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions. The Point-of-care lipid test report holds a massive importance when it comes to market definition, classifications, applications and engagements.

Global point of care (PoC) lipid test is expected to grow with a steady CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018, and the historic year of 2017. This rise in market value can be attributed to the rise in obesity levels that have resulted in a subsequent rise of cholesterol levels in the population.

Get Free Sample Copy of Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-poc-lipid-test-market

Market Definition: Global Point of Care (PoC) Lipid Test Market 

Point-of-care lipid test can be defined as the tests taking place near the patient as well as the care offered to them. This process of diagnosing the lipid levels in blood has seen a significant reduction in time taken between the diagnosis of the product and correct treatment or next course of action being offered to the patients.

Market Drivers

  • Increasing adoption of home-based diagnostic tests and POC testing devices in the home-care; this factor is expected to act as a driver for the market growth
  • Increasing levels of population involved in unhealthy eating habits has seen a result in adoption of lipid tests and services due to the increase in levels of cholesterols

Market Restraint

  • Lack of confidence over the various point-of-care testing products due to the product recalls from the various market competitors; this factor is expected to act as a restraint to the market growth

 Segmentation: Global Point of Care (PoC) Lipid Test Market 

  • By Product
    • Consumables
    • Instruments
  • By Application
    • Hyperlipidemia
    • Hypertriglyceridemia
    • Hyperlipoproteinemia
    • Tangier Disease
    • Familial Hypercholesterolemia
    • Others
  • By Mode
    • OTC-Based Testing
    • Prescription-Based Testing
  • By End-User
    • Hospitals
    • Clinics
    • Research & Diagnostic Laboratories
    • Others
  • By Geography
    • North America
      • US.
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain

Request for Detailed TOC at  https://databridgemarketresearch.com/toc/?dbmr=global-point-of-care-poc-lipid-test-market

Key Developments in the Market:

  • In October 2017, Abbott announced that they had completed the acquisition of Alere Inc. This acquisition is expected to form a global leader in the point-of-care diagnostics market due to both the companies’ expertise in the rapid diagnostics services.
  • In July 2016, Sinocare announced that they had completed the acquisition of PTS Diagnostics, this acquisition will help in establishing Sinocare’s division for rapid point-of-care product offerings due to PTS Diagnostics’ expertise in the same.

Competitive Analysis: Global Point of Care (PoC) Lipid Test Market 

Global point of care (PoC) lipid test market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of point of care (PoC) lipid test market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Inquiry Before Buying at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-point-of-care-poc-lipid-test-market

Key Market Competitors: Global Point of Care (PoC) Lipid Test Market 

Abbott; Abaxis; PTS Diagnostics; F. Hoffmann-La Roche Ltd; Samsung Medison Co., Ltd.; Bio-Rad Laboratories, Inc.; The Menarini Group; Nova Biomedical; AccuBioTech Co., Ltd.; BD; Chembio Diagnostic Systems, Inc.; Danaher; EKF Diagnostics; Johnson & Johnson Services, Inc.; Quidel Corporation; Sekisui Diagnostics; Siemens; Trinity Biotech Ireland are few of the major competitors present in the market.

Speak to Our Analyst:- https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-point-of-care-poc-lipid-test-market

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, South America, MEA, Europe or Asia | Mail us at sopan.gedam@databridgemarketresearch.com

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close